BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 32393283)

  • 21. Four-color fluorescence in-situ hybridization is useful to assist to distinguish early stage acral and cutaneous melanomas from dysplastic junctional or compound nevus.
    Lai Y; Wu Y; Liu R; Lu A; Zhou L; Jia L; Diao X; Li Z
    Diagn Pathol; 2020 May; 15(1):51. PubMed ID: 32393283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of fluorescence in situ hybridization in distinguishing acral melanoma in situ from acral junctional melanocytic nevus on the volar skin in Japanese patients.
    Takai S; Arai E; Shojiguchi N; Nakamura Y; Momose S; Fukuda T; Ishizawa K; Ogata D; Tsunemi Y; Nakamura K; Tsuchida T
    J Dermatol; 2023 May; 50(5):637-645. PubMed ID: 36539950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ancillary values of fluorescence in situ hybridization with different gene combination in diagnosis of malignant melanoma].
    Ren M; Bai QM; Kong YY; Zhou XY; Chang H; Cai X
    Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):827-833. PubMed ID: 32746551
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation.
    Morey AL; Murali R; McCarthy SW; Mann GJ; Scolyer RA
    Pathology; 2009; 41(4):383-7. PubMed ID: 19404853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted Genomic Profiling of Acral Melanoma.
    Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
    J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescence in situ hybridisation as an ancillary tool in the diagnosis of acral melanoma: a review of 44 cases.
    Su J; Yu W; Liu J; Zheng J; Huang S; Wang Y; Qi S; Ma X; Chen J; Zhang Y
    Pathology; 2017 Dec; 49(7):740-749. PubMed ID: 29037804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy.
    Kong Y; Sheng X; Wu X; Yan J; Ma M; Yu J; Si L; Chi Z; Cui C; Dai J; Li Y; Yu H; Xu T; Tang H; Tang B; Mao L; Lian B; Wang X; Yan X; Li S; Guo J
    Clin Cancer Res; 2017 Nov; 23(22):6946-6957. PubMed ID: 28830923
    [No Abstract]   [Full Text] [Related]  

  • 28. Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition).
    Guo J; Qin S; Liang J; Lin T; Si L; Chen X; Chi Z; Cui C; Du N; Fan Y; Gu K; Li F; Li J; Li Y; Liang H; Liu J; Lu M; Lu A; Nan K; Niu X; Pan H; Ren G; Ren X; Shu Y; Song X; Tao M; Wang B; Wei W; Wu D; Wu L; Wu A; Xu X; Zhang J; Zhang X; Zhang Y; Zhu H; ;
    Ann Transl Med; 2015 Dec; 3(21):322. PubMed ID: 26734632
    [No Abstract]   [Full Text] [Related]  

  • 29. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
    Ferlay J; Soerjomataram I; Dikshit R; Eser S; Mathers C; Rebelo M; Parkin DM; Forman D; Bray F
    Int J Cancer; 2015 Mar; 136(5):E359-86. PubMed ID: 25220842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TERT and AURKA gene copy number gains enhance the detection of acral lentiginous melanomas by fluorescence in situ hybridization.
    Diaz A; Puig-Butillé JA; Valera A; Muñoz C; Costa D; Garcia-Herrera A; Carrera C; Sole F; Malvehy J; Puig S; Alos L
    J Mol Diagn; 2014 Mar; 16(2):198-206. PubMed ID: 24374110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclin D1 expression in acral melanoma: a case control study in Sarawak.
    Ibrahim ZA; Narihan MZ; Ojep DN; Soosay AE; Pan KL
    Malays J Pathol; 2012 Dec; 34(2):89-95. PubMed ID: 23424770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax-embedded tissues and imprint-cytology specimens.
    Abásolo A; Vargas MT; Ríos-Martín JJ; Trigo I; Arjona A; González-Cámpora R
    Clin Exp Dermatol; 2012 Dec; 37(8):838-43. PubMed ID: 22731835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.
    Gerami P; Li G; Pouryazdanparast P; Blondin B; Beilfuss B; Slenk C; Du J; Guitart J; Jewell S; Pestova K
    Am J Surg Pathol; 2012 Jun; 36(6):808-17. PubMed ID: 22588064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescence in situ hybridization (FISH) analysis of melanocytic nevi and melanomas: sensitivity, specificity, and lack of association with sentinel node status.
    Fang Y; Dusza S; Jhanwar S; Busam KJ
    Int J Surg Pathol; 2012 Oct; 20(5):434-40. PubMed ID: 22561674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acral junctional nevus versus acral lentiginous melanoma in situ: a differential diagnosis that should be based on clinicopathologic correlation.
    Bravo Puccio F; Chian C
    Arch Pathol Lab Med; 2011 Jul; 135(7):847-52. PubMed ID: 21732773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases.
    Chi Z; Li S; Sheng X; Si L; Cui C; Han M; Guo J
    BMC Cancer; 2011 Feb; 11():85. PubMed ID: 21349197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.
    Vergier B; Prochazkova-Carlotti M; de la Fouchardière A; Cerroni L; Massi D; De Giorgi V; Bailly C; Wesselmann U; Karlseladze A; Avril MF; Jouary T; Merlio JP
    Mod Pathol; 2011 May; 24(5):613-23. PubMed ID: 21151100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions.
    Clemente C; Bettio D; Venci A; Scopsi L; Rao S; Ferrari A; Piris A; Mihm MC
    Pathologica; 2009 Oct; 101(5):169-74. PubMed ID: 20218056
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.